Abstract:OBJECTIVE:To investigate the clinical significance of the amount of regulatory T cells (Treg) in the peripheral blood CD4+ cells and tumor tissue in primary hepatocellular carcinoma (HCC).METHODS:From January 1999 to December 2000, 63 HCC patients underwent radical resection in Sun Yatsen University Cancer Center. Tregs in those patients were detected in the samples of preoperative peripheral blood by flow cytometry and also in tissue samples of the resected tumors by immunohistochemistry. All patients had been followed up till Dec 30, 2005. The correlations of Treg amount in the peripheral blood CD4+ cells and tumor tissue with clinicopathologic characteristics and prognosis of HCC were analyzed.RESULTS:The proportion of Treg/CD4+ in the peripheral blood was significantly higher in the patients with HCC than that in those with HBsAg positive (P < 0.01) and in the normal controls (P < 0.01). The mean number of Treg in tumor tissue was (15.69 +/- 13.29)/mm2, but none or very few Treg was detected in the normal liver tissue, para-cancerous liver tissue, and HBV-infected liver tissue. The proportion of Treg/ CD4+ in the peripheral blood was significantly positively correlated with the number of Treg in tumor tissue (P = 0.024). The 5-year survival in patients with high amount of Treg in both peripheral blood and tumor tissue was significantly poorer than that in the patients with low amount of Treg (P = 0.042, 0.019). The 5-year disease-free survival rate was significantly lower in the patients with high amount of Treg in tumor tissue than that in the patients with lower amount (P = 0.001).CONCLUSION:Regulatory T cells in the circulatory blood and tumor tissue are increased in patients with hepatocellular carcinoma. The increased amount of regulatory T cells either in peripheral blood or in the tumor tissue is pertaining to poor prognosis. Detection of regulatory T cells both in the preoperative peripheral blood CD4+ cells and tumor tissue may be used as a potential immunological prognostic indicator for the hepatocellular carcinoma patients after radical resection.

Increased Cd4(+)Cd69(+)Cd25(-) T Cells In Patients With Hepatocellular Carcinoma Are Associated With Tumor Progression

Increased Frequency of CD4+CD25highFoxP3+ Regulatory T Cells in Patients with Hepatocellular Carcinoma

[The Frequency, Phenotypes and Functions of CD4+ CD25+ Regulatory T Cells in Hepatocellular Carcinoma Patients].

Increased Liver-Infiltrating CD8+FoxP3+ Regulatory T Cells Are Associated with Tumor Stage in Hepatocellular Carcinoma Patients

The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma.

Increased Prevalence of Regulatory T Cells in the Tumor Microenvironment and Its Correlation with TNM Stage of Hepatocellular Carcinoma.

[Clinical Significance of the Proportion of CD4+CD25+ Regulatory T Cells in Peripheral Blood of Hepatocellular Carcinoma Patients: a Report of 117 Cases].

Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells

Expression of TIGIT/CD155 and Correlations with Clinical Pathological Features in Human Hepatocellular Carcinoma

CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis.

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy

Analysis of CD4+CD25+CD127low Regulatory T Cells in Peripheral Blood of Hepatocellular Carcinoma Patients with HBV Infection

Increased Intratumoral IL-17-producing Cells Correlate with Poor Survival in Hepatocellular Carcinoma Patients.

Human hepatocellular carcinoma-infiltrating CD4 + CD69 + Foxp3 − regulatory T cell suppresses T cell response via membrane-bound TGF-β1

Increased Expression of Cyclooxygenase-2 and Increased Infiltration of Regulatory T Cells in Tumors of Patients with Hepatocellular Carcinoma.

Impact of increased CD4+ CD25+ FOXP3+ regulatory T cells on tumor recurrence in liver transplantation for hepatocellular carcinoma

Phenotype and Function of Cxcr5(+)Cd45ra(-)Cd4(+) T Cells Were Altered in Hbv-Related Hepatocellular Carcinoma and Elevated Serum Cxcl13 Predicted Better Prognosis

CD69 + Vδ1γδ T cells are anti-tumor subpopulations in hepatocellular carcinoma

[Clinical Significance of Regulatory T Cells Proportion in the Peripheral Blood and Tumor Tissue in Primary Hepatocellular Carcinoma].

Selective Recruitment of Regulatory T Cell Through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis.

Clinical Prognostic Value of CD4+CD25+FOXP3+regulatory T Cells in Peripheral Blood of Barcelona Clinic Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma Patients.